248 related articles for article (PubMed ID: 28245482)
21. Comparative evolution of Alzheimer disease, vascular dementia, and mixed dementia.
Bowler JV; Eliasziw M; Steenhuis R; Munoz DG; Fry R; Merskey H; Hachinski VC
Arch Neurol; 1997 Jun; 54(6):697-703. PubMed ID: 9193204
[TBL] [Abstract][Full Text] [Related]
22. Neurological signs in relation to white matter hyperintensity volumes in memory clinic patients.
Staekenborg SS; de Waal H; Admiraal-Behloul F; Barkhof F; Reiber JH; Scheltens P; Pijnenburg YA; Vrenken H; van der Flier WM
Dement Geriatr Cogn Disord; 2010; 29(4):301-8. PubMed ID: 20389072
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
[TBL] [Abstract][Full Text] [Related]
24. Correlation between white matter hyperintensity and delusional symptoms in Alzheimer's disease.
Fan W; Ma S; Wang Z; Han Y; Liu X; Gu R; Cai Q
BMC Psychiatry; 2023 Dec; 23(1):914. PubMed ID: 38057778
[TBL] [Abstract][Full Text] [Related]
25. Influence of pneumonia complications on the prognosis of patients with autopsy-confirmed Alzheimer's disease, dementia with Lewy bodies, and vascular dementia.
Manabe T; Mizukami K; Akatsu H; Teramoto S; Yamaoka K; Nakamura S; Ohkubo T; Kudo K; Hizawa N
Psychogeriatrics; 2016 Sep; 16(5):305-14. PubMed ID: 26510708
[TBL] [Abstract][Full Text] [Related]
26. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia.
Bastos-Leite AJ; van der Flier WM; van Straaten EC; Staekenborg SS; Scheltens P; Barkhof F
Stroke; 2007 Dec; 38(12):3182-5. PubMed ID: 17962598
[TBL] [Abstract][Full Text] [Related]
27. Preclinical cognitive trajectories differ for Alzheimer's disease and vascular dementia.
Laukka EJ; Macdonald SW; Fratiglioni L; Bäckman L
J Int Neuropsychol Soc; 2012 Mar; 18(2):191-9. PubMed ID: 22264384
[TBL] [Abstract][Full Text] [Related]
28. The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.
Hallikainen I; Hongisto K; Välimäki T; Hänninen T; Martikainen J; Koivisto AM
J Alzheimers Dis; 2018; 61(4):1367-1376. PubMed ID: 29376861
[TBL] [Abstract][Full Text] [Related]
29. Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD.
van der Flier WM; Middelkoop HA; Weverling-Rijnsburger AW; Admiraal-Behloul F; Spilt A; Bollen EL; Westendorp RG; van Buchem MA
Neurology; 2004 May; 62(10):1862-4. PubMed ID: 15159496
[TBL] [Abstract][Full Text] [Related]
30. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction.
Senanarong V; Cummings JL; Fairbanks L; Mega M; Masterman DM; O'Connor SM; Strickland TL
Dement Geriatr Cogn Disord; 2004; 17(1-2):14-20. PubMed ID: 14560060
[TBL] [Abstract][Full Text] [Related]
31. Cerebral white matter disease is independently associated with BPSD in Alzheimer's disease.
Kandiah N; Chander R; Zhang A; Yee CC
J Neurol Sci; 2014 Feb; 337(1-2):162-6. PubMed ID: 24378065
[TBL] [Abstract][Full Text] [Related]
32. History of depression prior to Alzheimer's disease and vascular dementia verified post-mortem.
Brunnström H; Passant U; Englund E; Gustafson L
Arch Gerontol Geriatr; 2013; 56(1):80-4. PubMed ID: 23116976
[TBL] [Abstract][Full Text] [Related]
33. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
[TBL] [Abstract][Full Text] [Related]
34. Disorders of "taste cognition" are associated with insular involvement in patients with Alzheimer's disease and vascular dementia: "memory of food is impaired in dementia and responsible for poor diet".
Suto T; Meguro K; Nakatsuka M; Kato Y; Tezuka K; Yamaguchi S; Tashiro M
Int Psychogeriatr; 2014 Jul; 26(7):1127-38. PubMed ID: 24697954
[TBL] [Abstract][Full Text] [Related]
35. [Comparative study on the clinical features of Alzheimer's disease and vascular dementia].
Chen X; Zhang ZX; Huang JB; Wen HB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):122-7. PubMed ID: 15171546
[TBL] [Abstract][Full Text] [Related]
36. Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types.
Caputo M; Monastero R; Mariani E; Santucci A; Mangialasche F; Camarda R; Senin U; Mecocci P
Acta Psychiatr Scand; 2008 Jun; 117(6):455-64. PubMed ID: 18363771
[TBL] [Abstract][Full Text] [Related]
37. Hippocampal size and dementia in stroke patients: the Sydney stroke study.
Sachdev PS; Chen X; Joscelyne A; Wen W; Altendorf A; Brodaty H
J Neurol Sci; 2007 Sep; 260(1-2):71-7. PubMed ID: 17482210
[TBL] [Abstract][Full Text] [Related]
38. White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease.
Misquitta K; Dadar M; Louis Collins D; Tartaglia MC;
Neuroimage Clin; 2020; 28():102367. PubMed ID: 32798911
[TBL] [Abstract][Full Text] [Related]
39. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
[TBL] [Abstract][Full Text] [Related]
40. Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.
Price CC; Tanner JJ; Schmalfuss IM; Brumback B; Heilman KM; Libon DJ
J Alzheimers Dis; 2015; 48(3):833-47. PubMed ID: 26402109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
